High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor α activating mutations in gastrointestinal stromal tumors

作者: Joseph A. Holden , Carlynn Willmore-Payne , Domenico Coppola , Christopher R. Garrett , Lester J. Layfield

DOI: 10.1309/7TEH56K6WWXENNQY

关键词:

摘要: High-resolution melting amplicon analysis (HRMAA) was used to detect c- kit and platelet-derived growth factor receptor α ( PDGFRA ) activating mutations in 96 gastrointestinal stromal tumors (GISTs). HRMAA detected 87 GISTs (91%). Of the cases, 69 (79%) contained 18 (21%), mutations. One mutation–positive case an exon 9 mutation, ins FY at codon 503, that has not been previously described. mutation D842V del 843, also 3 (17%) were strongly positive for expression as measured by CD117 immunohistochemical analysis. 66 (96%) showed strong expression, but (4%) negative weak expression. (9%) wild type c-kit PDGFRA. wild-type 8 still whereas 1 expression. GISTs with found stomach, omentum, peritoneum small intestine. primarily intestine. HRMAA is a sensitive technique can be rapidly identify GISTs.

参考文章(21)
Seiichi Hirota, Koji Isozaki, Pathology of gastrointestinal stromal tumors Pathology International. ,vol. 56, pp. 1- 9 ,(2006) , 10.1111/J.1440-1827.2006.01924.X
Pamela C. Gibson, Kumarasen Cooper, CD117 (KIT): a diverse protein with selective applications in surgical pathology. Advances in Anatomic Pathology. ,vol. 9, pp. 65- 69 ,(2002) , 10.1097/00125480-200201000-00007
Isabelle Hostein, Michel Longy, Bernadette Gastaldello, Gaëlle Geneste, Jean-Michel Coindre, Detection of a new mutation in KIT exon 9 in a gastrointestinal stromal tumor. International Journal of Cancer. ,vol. 118, pp. 2089- 2091 ,(2006) , 10.1002/IJC.21607
Christopher D.M. Fletcher, Jules J. Berman, Christopher Corless, Fred Gorstein, Jerzy Lasota, B.Jack Longley, Markku Miettinen, Timothy J. O'Leary, Helen Remotti, Brian P. Rubin, Barry Shmookler, Leslie H. Sobin, Sharon W. Weiss, Diagnosis of gastrointestinal stromal tumors: A consensus approach Human Pathology. ,vol. 33, pp. 459- 465 ,(2002) , 10.1053/HUPA.2002.123545
Christopher L. Corless, Laura McGreevey, Ajia Town, Arin Schroeder, Troy Bainbridge, Patina Harrell, Jonathan A. Fletcher, Michael C. Heinrich, KIT Gene Deletions at the Intron 10−Exon 11 Boundary in GI Stromal Tumors The Journal of Molecular Diagnostics. ,vol. 6, pp. 366- 370 ,(2004) , 10.1016/S1525-1578(10)60533-8
Christopher L. Corless, Laura McGreevey, Andrea Haley, Ajia Town, Michael C. Heinrich, KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. American Journal of Pathology. ,vol. 160, pp. 1567- 1572 ,(2002) , 10.1016/S0002-9440(10)61103-0
Jerzy Lasota, Agnieszka Dansonka-Mieszkowska, Leslie H Sobin, Markku Miettinen, A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential Laboratory Investigation. ,vol. 84, pp. 874- 883 ,(2004) , 10.1038/LABINVEST.3700122
Mark G Herrmann, Jacob D Durtschi, L Kathryn Bromley, Carl T Wittwer, Karl V Voelkerding, Amplicon DNA Melting Analysis for Mutation Scanning and Genotyping: Cross-Platform Comparison of Instruments and Dyes Clinical Chemistry. ,vol. 52, pp. 494- 503 ,(2006) , 10.1373/CLINCHEM.2005.063438
Maria Debiec-Rychter, Raf Sciot, Axel Le Cesne, Marcus Schlemmer, Peter Hohenberger, Allan T. van Oosterom, Jean-Yves Blay, Serge Leyvraz, Michel Stul, Paolo G. Casali, John Zalcberg, Jaap Verweij, Martine Van Glabbeke, Anne Hagemeijer, Ian Judson, KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours European Journal of Cancer. ,vol. 42, pp. 1093- 1103 ,(2006) , 10.1016/J.EJCA.2006.01.030
Carlynn Willmore, Joseph A. Holden, Luming Zhou, Sheryl Tripp, Carl T. Wittwer, Lester J. Layfield, Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis. American Journal of Clinical Pathology. ,vol. 122, pp. 206- 216 ,(2004) , 10.1309/4E6UYBY62N2FCA6N